Thyroid, Endocrinology, and Diabetes

Dallas, Texas 75208

1 studies enrolling now · 5 studies all time

What they study most

ASCVD, Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Chronic Kidney Disease, Hypoparathyroidism, Obesity, Overweight, Overweight or Obesity, Type 2 Diabetes

Studies at this site

• Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity — Recruiting now
• A Registry for Participants With Chronic Hypoparathyroidism — Completed
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities — Running, not enrolling
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early